FDA Watch: New Test for Esophageal Conditions is Coming to the US
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.